We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MURFU market cap is 245.4M. The company's latest EPS is USD -0.4037 and P/E is -41.74.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.45M | -895k | -2.96M | -3.14M | -5.81M |
| Net Income | -2.09M | -3.74M | -3.55M | -5.38M | -6.46M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -4k | -1.2M | -5.26M |
| Net Income | -4k | 399k | -6.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 12.02M | 7.22M | 4.92M | 3.31M | 2.99M |
| Total Liabilities | 13.1M | 7.68M | 8.02M | 8.77M | 12.11M |
| Total Equity | -1.08M | -457k | -3.1M | -5.46M | -9.12M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 213k | 137.52M | 7.22M |
| Total Liabilities | 192k | 5.05M | 7.68M |
| Total Equity | 21k | -4.3M | -457k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -2.92M | -7.73M | -2.36M | -3.87M | -5.87M |
| Investing | 228k | 725k | N/A | -224k | -128k |
| Financing | 11.34M | 10.93M | N/A | 113k | 1.86M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6k | -1.31M | -7.73M |
| Investing | N/A | -134.9M | 725k |
| Financing | 55k | 136.5M | 10.93M |
| Market Cap | 245.4M |
| Price to Earnings Ratio | -41.74 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 59.77 |
| Price to Book Ratio | -553.06 |
| Dividend Yield | - |
| Shares Outstanding | 15M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 3.38 (18.95%) |
| Company Name | Murphy Canyon Acquisition Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.conduitpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
